(MedPage Today) — Patients should learn the eight characteristics of a symptom
Resumen: URSAPHARM GmbH y Novaliq GmbH anuncian un acuerdo de colaboración en Europa
SAARBRÜCKEN y HEIDELBERG–(BUSINESS WIRE)–URSAPHARM, una de las empresas líderes en el campo de la oftalmología en Europa, y Novaliq, empresa farmacéutica especializada en estudios clínicos con una plataforma tecnológica para la distribución de fármacos centrada en la oftalmología, han anunciado hoy un acuerdo de colaboración así como el lanzamiento europeo de EvoTears™. El comunicado en el idioma original, es la versión oficial y autorizada del mismo. La traducción es solamente un medio de ay
Increased Technology Use May Lead to Future Eye Health and Vision Issues
MINNEAPOLIS–(BUSINESS WIRE)–Today’s kids use digital devices for hours daily, which may have long term consequences for their eyes and vision. An annual comprehensive eye exam is essential for all children as they enter school.
Uncategorized
ClarVista obtains CE mark for Harmoni modular IOL system
ClarVista Medical has received CE mark approval and quality standard ISO 13485 certification for its Harmoni modular IOL system to correct vision in aphakic patients after cataract lens removal, according to a press release.“While these are noteworthy regulatory milestones achieved by ClarVista, this news is also of great significance for physicians and patients around the world who seek optimum vision after cataract extraction,” co-inventor Malik Kahook, MD, said in the release.
Uncategorized
URSAPHARM GmbH et Novaliq GmbH annoncent un accord de partenariat européen
SARREBRUCK et HEIDELBERG, Allemagne–(BUSINESS WIRE)–URSAPHARM, une des principales sociétés européennes spécialisées dans le domaine de l’ophtalmologie, et Novaliq, une entreprise de biotechnologie au stade clinique qui développe et commercialise des produits pharmaceutiques spécialisés et met à profit une approche technologique perturbatrice d’administration de médicaments ophtalmologiques, ont conjointement annoncé aujourd’hui qu’elles avaient conclu un accord de partenariat et qu’elles pro
Uncategorized
URSAPHARM GmbH and Novaliq GmbH Announce European Partnership Agreement
SAARBRÜCKEN, Germany & HEIDELBERG, Germany–(BUSINESS WIRE)–URSAPHARM and Novaliq jointly announce its partnership agreement as well as the initial European launch of EvoTears for the treatment of evaporative dry eye diseases.